Back

Crinetics Pharmaceuticals Stock Predictions

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Sell

CRNX
Crinetics Pharmaceuticals

Last Price:

$53.63

Seasonality Move:

-9.59%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Crinetics Pharmaceuticals Stock Forecast

Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 23% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Crinetics Pharmaceuticals Stock Undervalued?

The current Crinetics Pharmaceuticals [CRNX] share price is $53.50. The Score for CRNX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Crinetics Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 23% based on the past 6 years of stock performance.

Crinetics Pharmaceuticals Stock Rating

Sell

Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals overpriced?

Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Crinetics Pharmaceuticals Stock Price History

Is CRNX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

crinetics.com

52-Week Data

52-Week High:

62.53

52-Week Low:

33.67

Prediction Charts

Market Cap:

Price in USD:

53.50

Volume:

1.8M

Beta:

0.67

Technical Analysis

SMA50:

56.80

SMA100:

54.32

SMA200:

50.48

52-Wk Change:

55.12%

Stock Predictions

Is Crinetics Pharmaceuticals stock public?

Yes, Crinetics Pharmaceuticals is a publicly traded company.
What is the Crinetics Pharmaceuticals stock quote today?

The Crinetics Pharmaceuticals stock price is 53.50 USD today.
How to buy Crinetics Pharmaceuticals stock online?

You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-3	57.24	56.59	57.70	55.76
Dec-4	56.55	57.11	58.94	56.45
Dec-5	56.92	57.69	58.27	56.04
Dec-6	57.84	58.87	59.58	57.75
Dec-9	58.74	56.62	59.63	56.57
Dec-10	57.06	57.17	58.28	55.96
Dec-11	57.54	60.15	60.34	57.02
Dec-12	60.15	55.62	60.25	55.55
Dec-13	55.53	53.66	56.53	53.36
Dec-16	53.21	54.63	54.91	52.85
Dec-17	54.23	55.37	56.15	53.04
Dec-18	55.45	52.09	55.47	51.35
Dec-19	52.08	52.74	53.05	50.82
Dec-20	52.28	53.50	54.25	51.73

Crinetics Pharmaceuticals Earnings

Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Crinetics Pharmaceuticals Forecast Revenue Growth

Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.18 per share.

* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.